{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:10:26Z","timestamp":1778919026267,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05512-2","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:10:26Z","timestamp":1773385826000},"page":"1957-1969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding dexmedetomidine\u2019s multiple mechanisms in atherosclerosis: effects on lipid metabolism, inflammation, cholesterol efflux, and foam cell formation"],"prefix":"10.1007","volume":"481","author":[{"given":"Minli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"5512_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8563845","volume":"2019","author":"P Marchio","year":"2019","unstructured":"Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD (2019) Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev 2019:8563845. https:\/\/doi.org\/10.1155\/2019\/8563845","journal-title":"Oxid Med Cell Longev"},{"key":"5512_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","volume":"46","author":"S Barquera","year":"2015","unstructured":"Barquera S, Pedroza-Tob\u00edas A, Medina C, Hern\u00e1ndez-Barrera L, Bibbins-Domingo K, Lozano R, Moran AE (2015) Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 46:328\u2013338. https:\/\/doi.org\/10.1016\/j.arcmed.2015.06.006","journal-title":"Arch Med Res"},{"key":"5512_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/circresaha.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118:535\u2013546. https:\/\/doi.org\/10.1161\/circresaha.115.307611","journal-title":"Circ Res"},{"key":"5512_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/circulationaha.105.552737","volume":"113","author":"DC Goff Jr","year":"2006","unstructured":"Goff DC Jr., Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM (2006) Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113:647\u2013656. https:\/\/doi.org\/10.1161\/circulationaha.105.552737","journal-title":"Circulation"},{"key":"5512_CR5","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ (2022) Atherosclerosis: recent developments. Cell 185:1630\u20131645. https:\/\/doi.org\/10.1016\/j.cell.2022.04.004","journal-title":"Cell"},{"key":"5512_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","volume":"19","author":"GJ Koelwyn","year":"2018","unstructured":"Koelwyn GJ, Corr EM, Erbay E, Moore KJ (2018) Regulation of macrophage immunometabolism in atherosclerosis. Nat Immunol 19:526\u2013537. https:\/\/doi.org\/10.1038\/s41590-018-0113-3","journal-title":"Nat Immunol"},{"key":"5512_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen SE, Robinson AJB, Zurke YX, Monaco C (2022) Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol 19:522\u2013542. https:\/\/doi.org\/10.1038\/s41569-021-00668-4","journal-title":"Nat Rev Cardiol"},{"key":"5512_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL (2016) Sirt1 and the mitochondria. Mol Cells 39:87\u201395. https:\/\/doi.org\/10.14348\/molcells.2016.2318","journal-title":"Mol Cells"},{"key":"5512_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4161\/cc.10.4.14863","volume":"10","author":"S Stein","year":"2011","unstructured":"Stein S, Matter CM (2011) Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10:640\u2013647. https:\/\/doi.org\/10.4161\/cc.10.4.14863","journal-title":"Cell Cycle"},{"key":"5512_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bcp.2019.08.008","volume":"168","author":"PA Nguyen","year":"2019","unstructured":"Nguyen PA, Won JS, Rahman MK, Bae EJ, Cho MK (2019) Modulation of Sirt1\/NF-\u03baB interaction of evogliptin is attributed to inhibition of vascular inflammatory response leading to attenuation of atherosclerotic plaque formation. Biochem Pharmacol 168:452\u2013464. https:\/\/doi.org\/10.1016\/j.bcp.2019.08.008","journal-title":"Biochem Pharmacol"},{"key":"5512_CR11","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurheartj\/ehq107","volume":"31","author":"S Stein","year":"2010","unstructured":"Stein S, Lohmann C, Sch\u00e4fer N, Hofmann J, Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Bor\u00e9n J, McBurney MW, Landmesser U, L\u00fcscher TF, Matter CM (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 31:2301\u20132309. https:\/\/doi.org\/10.1093\/eurheartj\/ehq107","journal-title":"Eur Heart J"},{"key":"5512_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/157016112803520756","volume":"10","author":"S Winnik","year":"2012","unstructured":"Winnik S, Stein S, Matter CM (2012) SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Curr Vasc Pharmacol 10:693\u2013696. https:\/\/doi.org\/10.2174\/157016112803520756","journal-title":"Curr Vasc Pharmacol"},{"key":"5512_CR13","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","volume":"380","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Bin Kadiman S, McArthur CJ, Murray L, Reade MC, Seppelt IM, Takala J, Wise MP, Webb SA (2019) Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 380:2506\u20132517. https:\/\/doi.org\/10.1056\/NEJMoa1904710","journal-title":"N Engl J Med"},{"key":"5512_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfae041","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xiong Y, Min J, Zhu Y (2024) Dexmedetomidine improves lung injury after one-lung ventilation in esophageal cancer patients by inhibiting inflammatory response and oxidative stress. Toxicol Res (Camb) 13:tfae041. https:\/\/doi.org\/10.1093\/toxres\/tfae041","journal-title":"Toxicol Res (Camb)"},{"key":"5512_CR15","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1002\/iid3.1135","volume":"12","author":"K Lu","year":"2024","unstructured":"Lu K, Li X, Wu J (2024) Sirtuin 3 is required for the dexmedetomidine-mediated alleviation of inflammation and oxidative stress in nephritis. Immun Inflamm Dis 12:e1135. https:\/\/doi.org\/10.1002\/iid3.1135","journal-title":"Immun Inflamm Dis"},{"key":"5512_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05281-x","volume":"63","author":"J Fan","year":"2025","unstructured":"Fan J, Tasevski S, Mashal Y, Atoui T, Naseer Z, Zhang Z (2025) Sex- and cell type-specific effects of dexmedetomidine on ferroptosis in neurons and microglia following traumatic brain injury in juvenile mice. Mol Neurobiol 63:4. https:\/\/doi.org\/10.1007\/s12035-025-05281-x","journal-title":"Mol Neurobiol"},{"key":"5512_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07579-9","author":"L Jiang","year":"2024","unstructured":"Jiang L, Xiong W, Yang Y, Qian J (2024) Insight into cardioprotective effects and mechanisms of dexmedetomidine. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-024-07579-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"5512_CR18","doi-asserted-by":"publisher","unstructured":"National Research Council Committee for the Update of the Guide for the C, Use of, Laboratory A (2011) The national academies collection: reports funded by national institutes of health. In: Guide for the care and use of laboratory animals. National Academies Press (US) Copyright \u00a9 2011, National Academy of Sciences., Washington (DC). https:\/\/doi.org\/10.17226\/12910","DOI":"10.17226\/12910"},{"key":"5512_CR19","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.2147\/dddt.S388823","volume":"16","author":"Q Zuo","year":"2022","unstructured":"Zuo Q, Zhang G, He L, Ma S, Ma H, Zhai J, Wang Z, Zhang T, Wang Y, Guo Y (2022) Canagliflozin attenuates hepatic steatosis and atherosclerosis progression in Western diet-fed ApoE-knockout mice. Drug Des Devel Ther 16:4161\u20134177. https:\/\/doi.org\/10.2147\/dddt.S388823","journal-title":"Drug Des Devel Ther"},{"key":"5512_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.700","volume":"9","author":"L Tao","year":"2021","unstructured":"Tao L, Guo X, Xu M, Wang Y, Xie W, Chen H, Ma M, Li X (2021) Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice. Pharmacol Res Perspect 9:e00700. https:\/\/doi.org\/10.1002\/prp2.700","journal-title":"Pharmacol Res Perspect"},{"key":"5512_CR21","doi-asserted-by":"publisher","first-page":"51447","DOI":"10.18632\/oncotarget.17691","volume":"8","author":"X Yang","year":"2017","unstructured":"Yang X, Wei J, He Y, Jing T, Li Y, Xiao Y, Wang B, Wang W, Zhang J, Lin R (2017) SIRT1 inhibition promotes atherosclerosis through impaired autophagy. Oncotarget 8:51447\u201351461. https:\/\/doi.org\/10.18632\/oncotarget.17691","journal-title":"Oncotarget"},{"key":"5512_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22514\/sv.2023.109","volume":"19","author":"H Xu","year":"2023","unstructured":"Xu H, Chen X, Liu D, Yang Y (2023) Hispidulin protective impact on sepsis induced acute kidney injury is mediated by regulation of AKT and NF-\u03baB pathway. Signa Vitae 19:152\u2013159. https:\/\/doi.org\/10.22514\/sv.2023.109","journal-title":"Signa Vitae"},{"key":"5512_CR23","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1038\/s41598-020-65782-8","volume":"10","author":"MC Tung","year":"2020","unstructured":"Tung MC, Lan YW, Li HH, Chen HL, Chen SY, Chen YH, Lin CC, Tu MY, Chen CM (2020) Kefir peptides alleviate high-fat diet-induced atherosclerosis by attenuating macrophage accumulation and oxidative stress in ApoE knockout mice. Sci Rep 10:8802. https:\/\/doi.org\/10.1038\/s41598-020-65782-8","journal-title":"Sci Rep"},{"key":"5512_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1194\/jlr.M044198","volume":"55","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu Q, Xu Y, Liu C, Wang X, He X, Zhu N, Liu J, Wu Y, Li Y, Li N, Feng T, Lai F, Zhang M, Hong B, Jiang JD, Si S (2014) Rutaecarpine suppresses atherosclerosis in ApoE-\/- mice through upregulating ABCA1 and SR-BI within RCT. J Lipid Res 55:1634\u20131647. https:\/\/doi.org\/10.1194\/jlr.M044198","journal-title":"J Lipid Res"},{"key":"5512_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.22514\/sv.2023.020","volume":"19","author":"Q Wu","year":"2023","unstructured":"Wu Q, Zhao B (2023) Isoflurane ameliorates oxygen-glucose deprivation-induced cardiomyocyte injury through SIRT6\/DNMT1 pathway. Signa Vitae 19:154\u2013160. https:\/\/doi.org\/10.22514\/sv.2023.020","journal-title":"Signa Vitae"},{"key":"5512_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095452","volume":"9","author":"C Wu","year":"2014","unstructured":"Wu C, Luan H, Zhang X, Wang S, Zhang X, Sun X, Guo P (2014) Chlorogenic acid protects against atherosclerosis in ApoE-\/- mice and promotes cholesterol efflux from RAW264.7 macrophages. PLoS One 9:e95452. https:\/\/doi.org\/10.1371\/journal.pone.0095452","journal-title":"PLoS One"},{"key":"5512_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.883","volume":"11","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Huang Y, Gong C, Tang Y, Xiong J, Wang D, Liu X (2023) Dexmedetomidine attenuates inflammation and organ injury partially by upregulating Nur77 in sepsis. Immun Inflamm Dis 11:e883. https:\/\/doi.org\/10.1002\/iid3.883","journal-title":"Immun Inflamm Dis"},{"key":"5512_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.atherosclerosis.2018.04.039","volume":"274","author":"T Feng","year":"2018","unstructured":"Feng T, Liu P, Wang X, Luo J, Zuo X, Jiang X, Liu C, Li Y, Li N, Chen M, Zhu N, Han X, Liu C, Xu Y, Si S (2018) SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Atherosclerosis 274:172\u2013181. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.039","journal-title":"Atherosclerosis"},{"key":"5512_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.22514\/sv.2023.113","volume":"19","author":"H Yao","year":"2023","unstructured":"Yao H, Wang Y, Zhou W, Xu C, Ge X, Zhu J (2023) Chac1 silencing mitigates hemorrhagic shock-induced intestinal injury by inhibiting oxidative stress and ferroptosis. Signa Vitae 19:184\u2013193. https:\/\/doi.org\/10.22514\/sv.2023.113","journal-title":"Signa Vitae"},{"key":"5512_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.atv.14.1.133","volume":"14","author":"Y Nakashima","year":"1994","unstructured":"Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133\u2013140. https:\/\/doi.org\/10.1161\/01.atv.14.1.133","journal-title":"Arterioscler Thromb"},{"key":"5512_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokg\u00f6zo\u011flu L, Lewis EF (2019) Atherosclerosis. Nat Rev Dis Primers 5:56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z","journal-title":"Nat Rev Dis Primers"},{"key":"5512_CR32","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/cbdd.14324","volume":"102","author":"W Gao","year":"2023","unstructured":"Gao W, Du L, Li N, Li Y, Wu J, Zhang Z, Chen H (2023) Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in hyperlipidemic rats by inhibiting inflammation, oxidative stress and NF-\u03baB. Chem Biol Drug Des 102:1176\u20131185. https:\/\/doi.org\/10.1111\/cbdd.14324","journal-title":"Chem Biol Drug Des"},{"key":"5512_CR33","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/s0140-6736(20)30799-6","volume":"395","author":"RA Byrne","year":"2020","unstructured":"Byrne RA, Colleran R (2020) Aspirin for secondary prevention of cardiovascular disease. Lancet 395:1462\u20131463. https:\/\/doi.org\/10.1016\/s0140-6736(20)30799-6","journal-title":"Lancet"},{"key":"5512_CR34","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/01.cir.0000436752.99896.22","volume":"128","author":"JL Fleg","year":"2013","unstructured":"Fleg JL, Forman DE, Berra K, Bittner V, Blumenthal JA, Chen MA, Cheng S, Kitzman DW, Maurer MS, Rich MW, Shen WK, Williams MA, Zieman SJ (2013) Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation 128:2422\u20132446. https:\/\/doi.org\/10.1161\/01.cir.0000436752.99896.22","journal-title":"Circulation"},{"key":"5512_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jamacardio.2019.0777","volume":"4","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ (2019) 2018 American Heart Association\/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention. JAMA Cardiol 4:488\u2013489. https:\/\/doi.org\/10.1001\/jamacardio.2019.0777","journal-title":"JAMA Cardiol"},{"key":"5512_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA 321:277\u2013287. https:\/\/doi.org\/10.1001\/jama.2018.20578","journal-title":"JAMA"},{"key":"5512_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr., Tabas I, \u00d6\u00f6rni K, Kovanen PT (2019) Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 16:389\u2013406. https:\/\/doi.org\/10.1038\/s41569-019-0169-2","journal-title":"Nat Rev Cardiol"},{"key":"5512_CR38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.7150\/thno.80250","volume":"13","author":"G Zheng","year":"2023","unstructured":"Zheng G, Zhao Y, Li Z, Hua Y, Zhang J, Miao Y, Guo Y, Li L, Shi J, Dong Z, Yang S, Fan G, Ma C (2023) GLSP and GLSP-derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1\/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis. Theranostics 13:1325\u20131341. https:\/\/doi.org\/10.7150\/thno.80250","journal-title":"Theranostics"},{"key":"5512_CR39","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.2147\/dddt.S428024","volume":"17","author":"H He","year":"2023","unstructured":"He H, Liu P, Li P (2023) Dexmedetomidine ameliorates cardiac ischemia\/reperfusion injury by enhancing autophagy through activation of the AMPK\/SIRT3 pathway. Drug Des Devel Ther 17:3205\u20133218. https:\/\/doi.org\/10.2147\/dddt.S428024","journal-title":"Drug Des Devel Ther"},{"key":"5512_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148612","volume":"1822","author":"X Lian","year":"2023","unstructured":"Lian X, Zhang X, Chen W, Xue F, Wang G (2023) Dexmedetomidine mitigates neuroinflammation in an Alzheimer\u2019s disease mouse model via the miR-204-3p\/FBXL7 signaling axis. Brain Res 1822:148612. https:\/\/doi.org\/10.1016\/j.brainres.2023.148612","journal-title":"Brain Res"},{"key":"5512_CR41","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/circresaha.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA (2019) HDL and reverse cholesterol transport. Circ Res 124:1505\u20131518. https:\/\/doi.org\/10.1161\/circresaha.119.312617","journal-title":"Circ Res"},{"key":"5512_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/jcb.22667","volume":"111","author":"TS Lee","year":"2010","unstructured":"Lee TS, Pan CC, Peng CC, Kou YR, Chen CY, Ching LC, Tsai TH, Chen SF, Lyu PC, Shyue SK (2010) Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem 111:104\u2013110. https:\/\/doi.org\/10.1002\/jcb.22667","journal-title":"J Cell Biochem"},{"key":"5512_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nutres.2012.11.010","volume":"33","author":"SM Lee","year":"2013","unstructured":"Lee SM, Moon J, Cho Y, Chung JH, Shin MJ (2013) Quercetin up-regulates expressions of peroxisome proliferator-activated receptor \u03b3, liver X receptor \u03b1, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line. Nutr Res 33:136\u2013143. https:\/\/doi.org\/10.1016\/j.nutres.2012.11.010","journal-title":"Nutr Res"},{"key":"5512_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2013.01.017","volume":"229","author":"M Wang","year":"2013","unstructured":"Wang M, Wang D, Zhang Y, Wang X, Liu Y, Xia M (2013) Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus. Atherosclerosis 229:62\u201370. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.017","journal-title":"Atherosclerosis"},{"key":"5512_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s1388-1981(02)00343-8","volume":"1585","author":"R Salvayre","year":"2002","unstructured":"Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585:213\u2013221. https:\/\/doi.org\/10.1016\/s1388-1981(02)00343-8","journal-title":"Biochim Biophys Acta"},{"key":"5512_CR46","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/jcmm.12859","volume":"20","author":"W Li","year":"2016","unstructured":"Li W, Sultana N, Siraj N, Ward LJ, Pawlik M, Levy E, Jovinge S, Bengtsson E, Yuan XM (2016) Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. J Cell Mol Med 20:1664\u20131672. https:\/\/doi.org\/10.1111\/jcmm.12859","journal-title":"J Cell Mol Med"},{"key":"5512_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065477","volume":"8","author":"L Gu","year":"2013","unstructured":"Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y, Meng G, Xie L, Wang J, Xiao Y, Shan L, Zhou S, Wei L, Ferro A, Ji Y (2013) Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One 8:e65477. https:\/\/doi.org\/10.1371\/journal.pone.0065477","journal-title":"PLoS One"},{"key":"5512_CR48","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1002\/jcp.30300","volume":"236","author":"J Li","year":"2021","unstructured":"Li J, Meng Q, Fu Y, Yu X, Ji T, Chao Y, Chen Q, Li Y, Bian H (2021) Novel insights: dynamic foam cells derived from the macrophage in atherosclerosis. J Cell Physiol 236:6154\u20136167. https:\/\/doi.org\/10.1002\/jcp.30300","journal-title":"J Cell Physiol"},{"key":"5512_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12013-022-01081-5","volume":"80","author":"AD Dergunov","year":"2022","unstructured":"Dergunov AD, Baserova VB (2022) Different pathways of cellular cholesterol efflux. Cell Biochem Biophys 80:471\u2013481. https:\/\/doi.org\/10.1007\/s12013-022-01081-5","journal-title":"Cell Biochem Biophys"},{"key":"5512_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/11921","volume":"22","author":"S Rust","year":"1999","unstructured":"Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Den\u00e8fle P, Assmann G (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352\u2013355. https:\/\/doi.org\/10.1038\/11921","journal-title":"Nat Genet"},{"key":"5512_CR51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/01.Atv.0000055194.85073.Ff","volume":"23","author":"C Joyce","year":"2003","unstructured":"Joyce C, Freeman L, Brewer HB Jr., Santamarina-Fojo S (2003) Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 23:965\u2013971. https:\/\/doi.org\/10.1161\/01.Atv.0000055194.85073.Ff","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5512_CR52","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/circulationaha.108.793869","volume":"118","author":"L Yvan-Charvet","year":"2008","unstructured":"Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, Han S, Ishibashi M, Li R, Wang N, Tall AR (2008) Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118:1837\u20131847. https:\/\/doi.org\/10.1161\/circulationaha.108.793869","journal-title":"Circulation"},{"key":"5512_CR53","first-page":"129","volume":"3","author":"MJ Price","year":"2002","unstructured":"Price MJ, Shah PK (2002) New strategies in managing and preventing atherosclerosis: focus on HDL. Rev Cardiovasc Med 3:129\u2013137","journal-title":"Rev Cardiovasc Med"},{"key":"5512_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.012587699","volume":"99","author":"CW Joyce","year":"2002","unstructured":"Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB Jr, Santamarina-Fojo S (2002) The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice. Proc Natl Acad Sci USA 99:407\u2013412. https:\/\/doi.org\/10.1073\/pnas.012587699","journal-title":"Proc Natl Acad Sci USA"},{"key":"5512_CR55","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/jpp\/rgad053","volume":"75","author":"J Wang","year":"2023","unstructured":"Wang J, Wu R, Hua Y, Ling S, Xu X (2023) Naringenin ameliorates vascular senescence and atherosclerosis involving SIRT1 activation. J Pharm Pharmacol 75:1021\u20131033. https:\/\/doi.org\/10.1093\/jpp\/rgad053","journal-title":"J Pharm Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05512-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05512-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05512-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:39Z","timestamp":1778916519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05512-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5512"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05512-2","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Ethics Committee of Hospital of Chengdu University of Traditional Chinese Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}